Literature DB >> 27888347

Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series.

Dénes Zádori1, László Szpisjak1, László Madar2, Viktória Evelin Varga3, Bernadett Csányi4, Krisztina Bencsik1, István Balogh2, Mariann Harangi3, Éva Kereszty4, László Vécsei5,6, Péter Klivényi1.   

Abstract

Cerebrotendinous xanthomatosis (CTX) is a rare, genetically determined error of metabolism. The characteristic clinical symptoms are diarrhea, juvenile cataracts, tendon xanthomas and neuropsychiatric alterations. The aim of this study is to present a pair of identical adult twins with considerable differences in the severity of phenotype. With regards to neuropsychiatric symptoms, the predominant features were severe Parkinsonism and moderate cognitive dysfunctions in the more-affected individual, whereas these alterations in the less-affected patient were only very mild and mild, respectively. The characteristic increase in the concentrations of serum cholestanol and the lesion volumes in dentate nuclei in the brain assessed with magnetic resonance imaging were quite similar in both cases. The lifestyle conditions, including eating habits of the twin pair, were quite similar as well; therefore, currently unknown genetic modifiers or certain epigenetic factors may be responsible for the differences in severity of phenotype. This case series serves as the first description of an identical twin pair with CTX presenting heterogeneous clinical features.

Entities:  

Keywords:  Cerebrotendinous Xanthomatosis; Cognitive dysfunction; Heterogeneous phenotype; Identical twins; Parkinsonism

Mesh:

Year:  2016        PMID: 27888347     DOI: 10.1007/s10072-016-2776-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  8 in total

1.  Cerebrotendinous xanthomatosis with predominant parkinsonian syndrome: further confirmation of the clinical heterogeneity.

Authors:  M T Dotti; A Federico; R Garuti; S Calandra
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

Review 2.  Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.

Authors:  G N Gallus; M T Dotti; A Federico
Journal:  Neurol Sci       Date:  2006-06       Impact factor: 3.307

3.  Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis.

Authors:  A Verrips; L H Hoefsloot; G C Steenbergen; J P Theelen; R A Wevers; F J Gabreëls; B G van Engelen; L P van den Heuvel
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

Review 4.  Regulation of bile acid synthesis.

Authors:  J Y Chiang
Journal:  Front Biosci       Date:  1998-02-15

5.  Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis.

Authors:  A Mignarri; S Rossi; M Ballerini; G N Gallus; M Del Puppo; P Galluzzi; A Federico; M T Dotti
Journal:  J Neurol       Date:  2010-11-21       Impact factor: 4.849

Review 6.  Cerebrotendinous xanthomatosis.

Authors:  Ingemar Björkhem
Journal:  Curr Opin Lipidol       Date:  2013-08       Impact factor: 4.776

7.  Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.

Authors:  E Leitersdorf; A Reshef; V Meiner; R Levitzki; S P Schwartz; E J Dann; N Berkman; J J Cali; L Klapholz; V M Berginer
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Japanese triplets with cerebrotendinous xanthomatosis are homozygous for a mutant gene coding for the sterol 27-hydroxylase (Arg441Trp).

Authors:  Y Nagai; M Hirano; T Mori; Y Takakura; S Tamai; S Ueno
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

  8 in total
  8 in total

1.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

2.  Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report.

Authors:  Shingo Koyama; Yuma Okabe; Yuya Suzuki; Ryosuke Igari; Hiroyasu Sato; Chifumi Iseki; Kazuyo Tanji; Kyoko Suzuki; Yasuyuki Ohta
Journal:  BMC Neurol       Date:  2022-05-25       Impact factor: 2.903

Review 3.  Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).

Authors:  Gerald Salen; Robert D Steiner
Journal:  J Inherit Metab Dis       Date:  2017-10-04       Impact factor: 4.982

4.  Prominent Tendon Xanthomas and Abdominal Aortic Aneurysm Associated with Cerebrotendinous Xanthomatosis Identified Using Whole Exome Sequencing.

Authors:  Hayato Tada; Syota Inaba; Daria Pozharitckaia; Masa-Aki Kawashiri
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

5.  Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.

Authors:  Lan-Xiao Cao; Mi Yang; Ying Liu; Wen-Ying Long; Guo-Hua Zhao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

Review 6.  Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid.

Authors:  Mahjabin Islam; Nigel Hoggard; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2021-01-28

Review 7.  The clinical and imaging features of cerebrotendinous xanthomatosis: A case report and review of the literature.

Authors:  Chi Ma; Yan-De Ren; Jia-Chen Wang; Cheng-Jian Wang; Ji-Ping Zhao; Tong Zhou; Hua-Wei Su
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

8.  The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies.

Authors:  Aad Verrips; Maria Teresa Dotti; Andrea Mignarri; Bianca M L Stelten; Sue Verma; Antonio Federico
Journal:  Neurol Sci       Date:  2019-12-20       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.